
- Oncology NEWS International Vol 17 No 11
- Volume 17
- Issue 11
Colonoscopy proves cost-effective in young patients
Conducting colonoscopies for people in their mid 50s can save money, according to research presented at the 2008 American College of Gastroenterology meeting in Orlando, Fla. The savings averages $2 for every dollar spent, the study found.
Conducting colonoscopies for people in their mid 50s can save money, according to research presented at the 2008 American College of Gastroenterology meeting in Orlando, Fla. The savings averages $2 for every dollar spent, the study found.
Jianjun Li, MD, and colleagues at New York’s Maimonides Medical Center reported results of a study involving free screening colonoscopies for 248 consecutive patients (average age of 55). Nearly 45% had polyps. Follow-up testing demonstrated that fi ve individuals had early-stage colon cancer, and 22 had polyps larger than 1 cm.
The screening program cost $390,000. If colon cancer treatment had been delayed until the Medicare eligibility age of 65, the cost would have been nearly $1.3 million, Dr. Li said. If these patients had not been screened, their disease would have progressed undetected, said Judy Yee, MD, vice chair of radiology at the University of California, San Francisco. As people grow older, their risk of developing polyps increases, she said.
Articles in this issue
almost 17 years ago
Move to abandon anthracyclines in adjuvant breast cancer care is prematurealmost 17 years ago
Elaine Jaffe: At the forefront of clinical lymphoma biologyalmost 17 years ago
Clinical trials struggle to recruit, retain patientsalmost 17 years ago
Global financial woes threaten new UK radiotherapy centersalmost 17 years ago
UK health service urges drug cost cutsalmost 17 years ago
Birth length of at least 50 cm may bump up breast ca riskalmost 17 years ago
Obama, NCCN win endorsements in online poll surveysalmost 17 years ago
Philips Healthcare extends contract for image-guided oncologyalmost 17 years ago
US Oncology teams with RTOG to boost trial enrollmentalmost 17 years ago
Court finds Roche infringed on Amgen’s erythropoietin patentsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.